-
-
Your last patient has left the exam room with a prescription for birth control in her hand. You counseled on proper use and covered the expected side effects. Is she now protected against unintended pregnancy?
-
The teenager in front of you says she has some bumps on her genital area. A closer inspection shows several flesh-colored, flat growths on her vulva. What's your next move?
-
The woman in your exam room says she is experiencing a painful, burning sensation when urinating, and reports increased vaginal discharge. The test is positive for gonorrhea. What's your next move?
-
Recent research findings indicate that young women who use the commonly used epilepsy drug phenytoin for one year showed significant bone loss compared to women taking other epilepsy drugs.
-
If your clinical practice includes treatment of perimenopausal women, the subject of hot flashes is familiar territory for you. In a 2002 national survey of menopausal women, hot flashes (70%) led the top four reasons for seeking medical attention, followed by night sweats (68%), mood disturbances (50%), and sleep disturbances (49%).
-
As a women's health care provider, you are familiar with interstitial cystitis (IC) and painful bladder syndrome (PBS). It is estimated that at least 1 million Americans suffer from IC/PBS, most of them women.
-
-
This study of a very large prospective series of cardiac arrests in over 500 US hospitals found that survival rates were lower during nights and weekends, differences that persisted despite adjustments for patient, resuscitation event, and hospital characteristics.
-
The risk of venous thromboembolism was double in users of a transdermal contraceptive as compared to users of an oral contraceptive with a 35 mcg ethinyl estradiol component. Warning: no abstract skimming — it's worth your while to keep reading!
